limb-girdle muscular dystrophy
MeSH: D049288ORPHA: 2631 Treatment Available
Overview
muscular dystrophy characterized by weakening of the muscles of the hip and shoulders which comprise the limb girdle muscles
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Deflazacort Orphan | Oral tablet, Oral suspension | FDA Approved | 2 | 7d |
Classification & Codes
MeSH Code
D049288Orphanet Code
ORPHA:263limb-girdle muscular dystrophy
| MeSH | D049288 |
| Orphanet | ORPHA:263 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO